NAUT
Nautilus Biotechnology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.31
−1.84%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 100.32x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.52x
- Price / sales
- 692.98x
- Price / cash flow
- -5.60x
Enterprise value
- Enterprise value
- $234.0M
- EV / sales
- 551.86x
- EV / EBITDA
- -4.32x
- EV / EBIT
- -3.65x
- Market cap
- $293.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026